19
Participants
Start Date
September 30, 2009
Primary Completion Date
December 31, 2015
Study Completion Date
December 31, 2015
oprelvekin
injection, 50 mg/kg, once daily
Howard University, Washington D.C.
Pfizer Investigational Site, Washington D.C.
Montgomery Cancer Center, Mount Sterling
Pfizer Investigational Site, Mount Sterling
Gabrail Cancer Center Research, Dover
Pfizer Investigational Site, Dover
Gabrail Cancer Center Research, Canton
Pfizer Investigational Site, Canton
Pfizer Investigational Site, Middletown
Signal Point Clinical Research Center, LLC, Middletown
Pfizer Investigational Site, Laredo
South Texas Research Alliance LLC., Laredo
Pfizer Investigational Site, Santa Monica
Sarcoma Oncology Center, Santa Monica
Lead Sponsor
Pfizer
INDUSTRY